A class of anticholinergic drugs having the formula ##STR1## in which R.sup.1 is a carbocyclic or branched aliphatic group of 3 to 8 carbon atoms, R.sup.2 is a branched or linear aliphatic group containing 3 to 10 carbon atoms with 1 to 2 olefinic or acetylenic bonds and R.sup.3 is an alkyl or cyclic group of 4 to 12 carbon atoms containing a tertiary amino nitrogen, are described.

Anticancer drugs consisting of sugar and protein composed primarily of xylose which are obtained from the nutrient medium and tissue-medium of Basidiomycetes such as Lentinus edodes which has been cultured in a solid medium rich is xylose such as bagasse is described.

The present invention relates to an anxiolytic drug comprising as an active ingredient a 1-amino-5-halogenouracil represented by formula [I]: ##STR1## wherein X represents a halogen atom, or pharmaceutically acceptable salt thereof.

Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B).sub.b0--(C).sub.c0--NO.sub.2 wherein A contains the radical of a drug having an antiinflammatory or analgesic activity, B is a bivalent linking group wherein the precursor must meet the tests described in the application, C is a a bivalent linking group as defined in the invention.

Psychotropic drugs for treatment of psychoses containing caerulein or the pharmaceutically acceptable salts thereof as effective ingredient, and a method of treatment of psychoses comprising administering said drugs.

The invention relates to the use of cannabinoid compounds (derivatives of tetrahydrocannabinol) for decreasing cell proliferation in a mammal.

The treatment of psychiatric or neurological disorders using selenium in combination with drugs used conventionally to treat such disorders is disclosed. The daily dose of selenium is between 10 .mu.g and 2000 .mu.g per day.

A compound represented by the formula: ##STR00001## wherein A is thiazolyl or the like, X is a bond or the like, m is an integer of 0 to 4, Y is optionally substituted alkyl or the like, Z is a substituent represented by the formula: ##STR00002## wherein R.sup.3 is hydrogen atom or the like, R.sup.4 and R.sup.5 are each independently hydrogen atom or the like, W is --(CH.sub.2).sub.n-- (n is 0, 1, 2 or 3) or the like, a prodrug thereof, its pharmaceutically acceptable salt, or its solvate is use...

The invention relates to the use of cannabinoid compounds (derivatives of tetrahydrocannabinol) for decreasing cell proliferation in a mammal.

The invention relates to the use of peptides individually or in combination, for treating and/or preventing angiogenesis. It also relates to the use of peptide analogs or a combination of peptides referred to as MuJ-7 as anticancer drugs in restricting the tumor growth and spread by inhibiting tumor angiogenesis. MuJ-7, in addition inhibits metastasis through its antiangiogenic activity in all cancers. The invention also relates to a pharmaceutical composition containing either individual peptid...